Two clones were isolated in a three-hybrid screen of a rat fetal brain P5 cDNA library with an intronic splicing enhancer of the amyloid precursor protein (APP) gene as RNA bait. These clones represent the rat homologues of the previously described genes CUG-binding protein (CUG-BP) and Siah-binding protein (Siah-BP). Both interact in a sequence-specific manner with the RNA bait used for library screening as well as with the CUG repeat. In contrast, no interactions were observed in the three-hybrid assay with other baits tested. In two-hybrid assays, Siah-BP interacts with U2AF65 as well as with itself. EWS, an RGG-type RNA-binding protein associated with Ewing sarcoma, was identified as an interacting partner for the CUG-BP homologue in a twohybrid assay for protein±protein interactions performed with various factors involved in RNA metabolism. Splicing assays performed by RT-PCR from cells cotransfected with certain cDNAs and an APP minigene, used as a reporter, indicate exclusion of exon 8 if the CUG-BP homologue is present. We conclude that clone AF169013 and its counterpart in human CUG-BP could be the trans-acting factors that interact with the splicing enhancer downstream of exon 8, and in this way influence alternative splicing of the APP minigene.
Alternative usage of splice sites requires cis-acting elements, such as 5 H and 3 H consensus sequences for the binding of the basic splicing machinery, as well as gene-specific elements for binding of regulatory trans-acting factors [1, 2] . Consequently, specific exon or intron sequences capable of strongly stimulating or repressing splice-site usage have been designated splicing enhancers or silencers, respectively. Although several proteins have been identified in Drosophila that act in this way [3±6] , the regulatory molecules that direct alternative splicing in vertebrates remain elusive. Furthemore, reports describing such causative interactions in vertebrates have been from simple biochemical analysis and not genetic functional assays. One of the most extensively clarified cases reported so far describes biochemical interactions within the c-src gene. Analysis of mouse c-src gene indicates that the neuronal inclusion of the N1 exon requires an intronic splicing-enhancer sequence between 117 and 1142 nucleotides downstream of the exon [7] . The central, most conserved, portion of this enhancer sequence (nucleotides 38±70) is called the downstream control sequence [8] , which binds to a complex of regulatory proteins that is important in allowing 18-nucleotide exon N1 splicing. A protein containing four K homology RNA-binding domains is shown to be the key component in the co-operative assembly of the multiprotein complex at the splicing enhancer [9] . The latest report demonstrates by genetic and biochemical methods that Nova-1 regulates in a sequencespecific manner alternative splicing of two inhibitory receptor pre-mRNAs, glycine receptor a2 and GABA A [10] .
By the use of splicing assays and minigenes, sequences regulating neuron-specific splicing have been found in vertebrates. Several forms of the amyloid precursor protein (APP) mRNA can be generated by alternative splicing. Of these, the APP695 mRNA, in which exons 7 and 8 are excluded, is expressed specifically in neurons, suggesting that this alternative splicing is regulated in a neuron-specific manner [11, 12] . Mutational analysis of an intron region flanking exon 8 shows two distinct cis-acting elements that modulate the splicing of this exon of the APP gene in a sequence-dependent manner. Both elements are located upstream of the branchpoint sequence, the first at 242 to 247 and the second at 236 to 238 upstream of exon 8 [13] . Agrin, an extracellular matrix protein expressed in both neurons and muscle cells, is differentially spliced in neuronal tissues, and inclusion of exon Y/28 is regulated by a sequence lying 15±68 nucleotides downstream of the alternatively spliced exon [14] . A potential splicing enhancer also exists in exon EN of the CLB gene [15] .
Several methods have been established for finding proteins that bind to given RNA sequences, such as standard molecular methods, including RNAse CV1 footprinting assays, gel-shift assays, conventional biochemical purification (reviewed in [16] ), and some new methods, such as systematic evolution of ligands by expontential enrichment (SELEX) [17±21], a new affinity-chromatography strategy called StreptoTag [22] , and one that uses a reporter gene system [23] . Recently, the threehybrid system has been established, in which RNA-binding proteins can be isolated by screening of expression libraries in yeast with a given RNA bait [24, 25] . This system has been used succesfully to isolate a number of mRNA-binding proteins, but so far has not identified any factors that influence differential splicing [26±30] . In the present study, we have examined various sequences described as splicing enhancers in order to clone the corresponding RNA-binding proteins. Four screens were performed with three different RNA baits expressing such sequences. Two RNA-binding proteins were isolated in a screen with an intronic splicing enhancer from the APP gene. Both clones interact with the RNA bait in a sequence-specific manner. One of them, homologous to the previously described CUG-binding protein (CUG-BP), influences splicing of an APP minigene in transfection experiments. This is also shown for the human CUG-BP gene. We conclude that human CUG-BP as well as its counterparts could be involved in post-transcriptional regulation of the APP gene as the trans-acting factors. Construct RSVA689, containing the APP minigene, was a gift from Y. Sakaki. pEGFP-C2 vector (Clontech) was used to clone cDNAs (human CUG-BP, clones AF169013 and AF165892) in-frame with green fluorescent protein (GFP). These expression vectors were used in transfection experiments. Plasmids used in the two-hybrid system contain the full coding regions of corresponding genes, cloned into GBT9 (bait) or pGAD424 (prey) vectors.
E X P E R I M E N T A L P R O C E D U R E S
The cDNA library was constructed by Stratagene (catalogue number 838401) and contains about 3.7 Â 10 6 primary plaques. Oligo(dT)-primed cDNAs were isolated from postnatal P5 rat brain mRNA and cloned into EcoRI and XhoI sites of the HybriZAP vector. The library was then converted by in vivo mass excision to a pAD-GAL4 target plasmid library and replicated in a l-resistant Escherichia coli strain, according to the manufacturer's instructions.
Cell transfections and RNA isolation
The calcium phosphate method of transfection was used in all experiments. A 1 mg portion of each plasmid was used to transfect the HEK293 cell line grown in six-well plates. To keep an equal quantity of DNA, the C2EFGP vector was used as carrier. One day later the cells were lysed and total RNA was prepared using an RNeasy mini kit (Qiagen) as described by the manufacturer. The experiment was repeated twice. 
RT-PCR analysis
Total RNA (1±3 mg) was mixed with 25 pm reverse primer derived from exon 9 of the APP gene, and incubated for 5 min at 70 8C. cDNA synthesis was performed for 1 h at 42 8C with SuperScript reverse transcriptase according to the manufacturer's instructions (Life Technologies), and terminated at 58 8C for 15 min. A 5-mL portion of the cDNA pool was taken for PCR with oligonucleotides derived from exon 6 and exon 9. PCR was performed in a Perkin±Elmer 9600 thermocycler for 30 cycles (58 8C for 0.5 min, 72 8C for 0.5 min, 93 8C for 0.3 min). The primers used for the amplification were as follows: forward, 5
Yeast two-hybrid and three-hybrid systems
The three-hybrid screens were performed as described previously [24] . The yeast strain L40-coat was transformed with bait and cDNA library plasmids, and plated on to synthetic dextrose (SD)-agar plates without leucine, histidine and uracil, and with 5 mm 3-aminotriazole. After one week, colonies were picked and restreaked on SD-agar without leucine and with fluorooratic acid (5-FOA) to eliminate the bait plasmid. These clones were restreaked on SD-agar without leucine, and assayed for bait-independent growth. Selected clones were sequenced and, if they contained any sensible ORFs, used for further assays. To test RNA-binding specificity, several different RNA plasmids were reintroduced into selected clones by mating. For this the second yeast strain, R40-coat, with the opposite mating type of L40-coat, was used. The twohybrid assay was performed according to the Clontech mating protocol, using yeast strains HF7c and Y187.
R E S U L T S
Cloning factors that interact with the APP splicing enhancer
For three-hybrid screens, a cDNA library from postnatal P5 rat brain was used. Accordingly, sequences derived from potential splicing enhancers of genes differentially spliced in the brain were selected. Three such sequences, derived from the CLB, agrin and APP genes were cloned downstream from the MS2 sequence in pIIIAMS-2 vector to construct hybrid RNAs. These bait constructs were cotransformed with cDNA prey plasmids in yeast and screened for interactions. Two screens performed with the EN exon of CLB as bait and one screen with sequences from an intronic splicing enhancer of the agrin gene were not successful. The fourth screen was performed with a potential splicing enhancer of the APP gene and yielded about 65 clones. Of the 10 clones selected for sequencing, only two had ORFs and both were by homology putative RNA-binding proteins (Figs 1 and 2) . One of them, designated AF169013, is almost identical in the coding region with the previously described rat Elav-type ETR-R3b and mouse NAPOR-3 genes, the homologue of which in man is the Nab50/CUG-BP gene known also as NAPOR-1 (Fig. 1A) . NAPOR-1 (neuroblastoma apoptosisrelated RNA-binding protein) was isolated previously by differential display from apoptotic neuroblastoma cells [31] . The Nab50/CUG-BP protein was identified first as an interacting partner for yeast hnRNP Nab2p in a two-hybrid screen, and for the second time as a protein that binds RNA in a sequence-specific manner [32, 33] . Its binding activity was specific for the CUG repeat, but not for single-stranded or double-stranded DNA CTG repeats. It was suggested that the 
CUG repeat found in the 3
H UTR of the myotonin protein kinase mRNA is a target for CUG-BP. There are two known isoforms of human CUG-BP, which are distributed in both cytoplasmic and nuclear fractions. The CUG-BP1 cDNA contains an ORF that encodes a 482-amino-acid protein with three RNA-recognition motif (RRM) domains. The AF169013 clone isolated in our screen is a partial cDNA, coding for the C-terminal part of the corresponding protein and large 3 H UTR. In a region coding for 3d C-terminal RRM, this clone shows high homology to ETR-R3b as well as to human CUG-BP (Fig. 1B) . 3
H UTR resembles that of the mouse NAPOR-3 gene (not shown).
The second clone, AF165892, is a rat counterpart of the human Siah-BP/PUF60 gene (Fig. 2) . Siah-BP (GenBank accession number U51586; Hu, Holloway, and Bowtell, personal communication) was initially isolated as an interacting partner of sina ring-finger protein, using the two-hybrid system. Rat Siah-BP shows predominant cytoplasmic localization as a GFP fusion protein (data not shown). This result contradicts the report describing the PFU60gene, which seems to be an isoform of Siah-BP, as splicing factor [34] .
The isolated clone is 1861 nt long, contains an ATG at the 5 H end and ends with a TGA stop codon (nucleotides 1688±1690), which is followed by a short 3 H UTR (Fig. 1B) . The cDNA contains three regions with trinucleotide repeats (nucleotides 107±137, 303±362 and 1153±1369) found in a wide variety of unrelated genes. The predicted product of the Table 1 . Specific interactions of clones isolated in the three-hybrid screen with different baits. Both RNA-expressing plasmid (containing sequence of natural or artificial splicing enhancer derived from agrin, clathrin light chain B, amyloid precursor protein genes or CUG repeat, respectively) and clone isolated in the three-hybrid screen (partial cDNA of CUG-BP-related gene, AF169013, or rat Siah-BP, AF165892, respectively) were introduced into yeast by the mating protocol, and plated on SD-agar without leucine, uracil, histidine and with 5 mm 3-aminotriazole. Growth was estimated after 3 days of incubation at 30 8C. (1) Weak interaction in the three-hybrid assay; (1 1 1) strong interaction; (±) no interaction. IRE, iron-regulatory protein responsive element.
AF169013
AF165892
ORF is a protein with three RRM domains, which are highly conserved between the rat and human proteins (Fig. 2B ). PUF60 and Siah-BP are identical except for a 17-amino-acid insertion in PUF60 (position 102/103 of Siah-BP) and one difference in protein sequence (G at position 105 in Siah-BP, R in position 123 in PUF60).
No homology outside of the RRM domains exists between CUG-BP and Siah-BP, but these proteins show similar compositions. Both contain three RRMs, two in the N-terminus and one in the C-terminus. The RRM domains of these proteins show about 30% amino-acid identity and 50% similarity at the amino-acid level to the RRM domains of polyadenylate-binding protein, spliceosome-associated protein 49, splicing factor U2AF 65KD subunit, hnRNP A3, Hu proteins, and weaker homologues with the sex-lethal protein of Drosophila.
CUG-BP and Siah-BP specifically bind sequences derived from the APP splicing enhancer
Both clones isolated in the three-hybrid screen specifically interact with the bait used for screening, as confirmed in the three-hybrid mating tests of specificity (Table 1) . Whereas interaction with the APP splicing enhancer element was strong, only weak interactions were observed with bait containing the CUG repeat, and no interactions were observed between either prey and a number of different RNA baits, including other potential splicing-enhancer sequences. Interestingly, the CUG-BP-like clone, containing only one of the three RRM domains, is sufficient to interact with RNA bait in a sequencespecific manner.
CUG-BP is a potential regulator of alternative splicing of the APP gene
To examine whether the factors isolated in our three-hybrid screen could influence alternative splicing in vivo, cotransfection experiments with an APP minigene were performed. Construct RSVA689 [13] , consisting of exons 6±9 where exon 7 is deleted, was transfected into the HEK293 cell line alone or together with human CUG-BP, deletion mutant AF169013 or the rat Siah-BP homologue AF165892 expression vectors. In the HEK293 cell line, in which the endogenous APP gene is expressed, exon 8 is included in only a fraction of mature RNAs (Fig. 3, lane 1) . After introduction of the RSVA689 construct into cells, exon 8 is expressed strongly from the minigene, and is abundantly present in the processed RNA (Fig. 3, lane 5) . On coexpression of the reporter gene with human CUG-BP, exon 8 is strongly excluded (Fig. 3, lane 2) . A weaker effect on the exclusion of exon 8 was seen with the portion of rat CUG-BP isolated in the screen (Fig. 3, lane 3) . No effects on splicing were observed with Siah-BP (Fig. 3,  lane 4) .
Interaction of CUG-BP and Siah-BP with other RNA-binding proteins
Factors that regulate differential splicing are expected to bind , the minigene (RSVA689), the expected pre-mRNA and size of PCR products, amplified from these using the indicated primers (forward and reverse). Table 2 . Interaction of CUG-BP and Siah-BP with certain RNAbinding proteins in the two-hybrid assay. The full coding regions of human CUG-BP or rat Siah-BP were subcloned in GAD424 vector (Stratagene); other cDNAs were cloned in GBT9 vector. Constructs were introduced into yeast by the mating protocol, and diploid cells were plated on SD-agar without leucine, tryptophan, histidine, and with 5 mm 3-aminotriazole, and incubated for 3 days at 30 8C. CUG-BP, human CUG-BP1; Siah-BP, clone AF165892 homologues to human Siah-BP; ELAV, rat ELAV-like gene [46] ; SF2, human SF2/ASF [47] ; U2AF65, human gene [48] ; U2AF35, human gene [49] ; SC35, human gene [50] ; X16, mouse SRp20 [51] ; tra2b1, human tra2b1 [52] ; SAF-B, rat SAF-B [53] ; EWS, rat gene (obtained from Oliver Stoss, MPI for Neurobiology, Munich, Germany).
CUG-BP
Siah-BP
not only to their RNA target, but perhaps also to the essential splicing machinery, and may act in a complex with other RNA-binding proteins. To investigate these possible interactions, cDNAs coding for proteins involved in RNA metabolism, including essential splicing factors, were tested for protein±protein interactions with CUG-BP and Siah-BP in the two-hybrid system (Table 2) . Human CUG-BP interacted only with EWS, an RGG-type RNA-binding protein associated with Ewing sarcoma. Siah-BP interacts with U2AF65, the large subunit of the essential splicing factor U2AF, as well as with itself.
D I S C U S S I O N
Splicing enhancers and repressors have been described as short sequences, without loops or structural conformations, that influence differential splicing. These elements are diverse in sequence and location relative to the regulated splice site, and function as tissue-specific and/or stage-specific regulatory elements for alternative splicing. Therefore, such sequences can be more correctly defined as cis-acting elements regulating alternative splicing. It has recently been shown that multiple enhancer elements additively increase the efficiency of splicing [35] . The effect of a single cis-acting element depends on the natural sequence and environmental context, for example the presence of tissue-specific trans-acting factors. The involvement of such factors make differential splicing more complex but at the same time more precise, allowing fine-tuning of tissue-specific or developmentally regulated expression. However, many natural sequences that match the simple motifs for splicing enhancers could fail to function in artificial systems unless they are placed in an appropriate context. At present, there is too little information about how splicing enhancers function: which proteins bind these sequences; what causes the tissue-specific and stage-specific assembly of these proteins into a splicing-enhancer complex; how such a complex interacts with obligatory splicing components, etc. It has been postulated, mainly on the basis of studies on Drosophila, that SR proteins may be trans-acting factors that regulate alternative splicing, and whose targets are splicing enhancers (reviewed in [2, 36] ). Experiments performed with different splicing factors in mammalian systems show that they act non-specifically and can bind several different sequences strongly [19] . Therefore the SELEX procedure and statistical methods used to identify targets of RNA-binding proteins are useful in identification of functional splicing enhancers but not their natural targets [37] .
A different approach, utilizing the biochemical purification of RNA-binding proteins on an RNA-affinity column, has been used successfully to isolate the protein complexes associated with a splicing enhancer. Surprisingly, KSRP protein cloned as a component of a protein complex assembled on c-src splicing enhancer cannot individually bind that sequence (D. Black, UCLA, USA, personal communication). The same effect has been observed in the three-hybrid assay: KSRP was not able to interact with any RNA bait tested in our laboratory (data not shown). Furthermore, no other splicing factors or RNA-binding proteins tested so far in our laboratory interacts with RNA baits in the three-hybrid assay. This includes the target sequences described for WT1 and SC35, U2AF35, human tra2b, mouse X16, hnRNP A1, SF2, U170K, hnRNPG and some other factors.
An increasing number of proteins appear to be multifunctional, participating in different post-transcriptional events. WT1, at first thought to be a typical transcription factor, may also be involved in splicing, as well as in regulation of mRNA [38] . The 1KTS isoform of WT1 is found preferentially in nuclear speckles, and colocalizes with snRNPs and splicing factors, such as the Sm proteins, U170 and U2AF65. Additional evidence indicates involvement of WT1 in post-transcriptional events, as WT1 also binds to the IGF-2 transcript. CUG-BP was initially reported to bind to the CUG repeat found in the 3 H UTR of myotonin protein kinase mRNA, regulating its cellular localization and/or transport/stability as well as being associated with poly(A)-rich RNA [32] . Our data indicate that this factor could also be involved in pre-mRNA processing, and could be a regulator of differential splicing in the APP gene.
Recently, a group of neuronal cytoplasmic Elav-like proteins have been described. These proteins, like CUG-BP and Siah-BP, contain three RRMs, and it has been shown that each RRM plays a distinct role in RNA-binding activity. The first RRM of mHuC is required for AU-rich element binding, and this binding is greatly enhanced when the first RRM is connected to the second RRM. The third RRM has specific affinity for the poly(A)-rich sequence [39] . The third RRM of the CUG-BP homologue described in this paper alone possesses sequence-specific RNA-binding activity in the three-hybrid system. However, it is not efficient in driving splicing from the APP minigene in transfection experiments, indicating that the activities of the three RRM domains of CUG-BP are not redundant.
Siah-BP interacts with the sequence derived from the APP gene as well as with CUG repeat, and binds RNA in a sequence-specific manner. On the other hand, this factor does not interact with the APP minigene in transfection experiments. Cytoplasmic localization of the GFP±rat Siah-BP fusion protein is at variance with studies on PFU60 (as briefly discussed above). This also contradicts the fact that Siah-BP interacts with U2AF65 in the two-hybrid system, as well as the results of Page-McCaw et al., describing PUF60 as a splicing factor [34] . This is the first publication describing the Siah-BP/ PFU60 gene, and its biochemical and genetic features need to be further investigated. It should be mentioned that a lot of splicing factors do not have unequivocal cellular localization and function, and shuttle between the nucleus and cytoplasm [40±42]. CUG-BP/Nab50 has been shown to be present in both cytoplasmic and nuclear fractions, and its intranuclear distribution is highly variable between different cell types [32] . If the HEK293 cell line is not an appropriate test system for analysing Siah-BP function, then all experiments should be repeated in other cell lines. The interaction of Siah-BP with itself in the two-hybrid system is confirmed by functional analysis of the PFU60 protein. The third RRM domain has been shown to mediate protein±protein interaction to form stable dimers of PFU60 [34] . If Siah-BP binds RNA as a homodimer or heterodimer, it could be an interesting phenomenon for further investigation.
Preliminary data on proteins that interact with the isolated clones indicate possible links to other cell pathways. EWS, an RNA-binding protein [43] that interacts in the two-hybrid assay with CUG-BP, also copurifies with another RNA-binding protein and protein kinase C substrate, TLS/FUS [44] as well as with the splicing factor PSF [45] . EWS also interacts with ESAF (O. Stoss, MPI for Neurobiology, Munich, Germany, personal communication), described as an important factor involved in pre-mRNA metabolism.
In this report, we have cloned nuclear RNA-binding protein using an RNA target described previously as a splicing enhancer in the APP gene. No such factors have previously been isolated by the three-hybrid approach. Two other sequences regarded as potential splicing enhancers were not effective in the isolation of RNA-binding proteins. This may indicate that the baits used for the cloning of proteins that bind to splicing enhancers/silencers must possess other features as for cloning of the cytoplasmic proteins that bind mRNA. If multiprotein complexes bind preferentially to such sequences rather than individual factors, biochemical purification of these complexes and subsequent cloning of their components would be more appropriate. If enhancer-binding proteins require other proteins to stabilize RNA binding, the baits should be modified to combine splicing-enhancer sequences with consensus 5 H or 3
H sequences, polypyrimidine tract, etc. and tested in the three-hybrid screens.
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